These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 17356128

  • 1. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
    Yamaguchi I, Lopez-Guisa JM, Cai X, Collins SJ, Okamura DM, Eddy AA.
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
    [Abstract] [Full Text] [Related]

  • 2. Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis.
    Gonzalez J, Klein J, Chauhan SD, Neau E, Calise D, Nevoit C, Chaaya R, Miravete M, Delage C, Bascands JL, Schanstra JP, Buffin-Meyer B.
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1511-8. PubMed ID: 19934371
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
    Yang J, Liu Y.
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.
    Oda T, Jung YO, Kim HS, Cai X, López-Guisa JM, Ikeda Y, Eddy AA.
    Kidney Int; 2001 Aug; 60(2):587-96. PubMed ID: 11473641
    [Abstract] [Full Text] [Related]

  • 8. Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice.
    Matsuo S, López-Guisa JM, Cai X, Okamura DM, Alpers CE, Bumgarner RE, Peters MA, Zhang G, Eddy AA.
    Kidney Int; 2005 Jun; 67(6):2221-38. PubMed ID: 15882265
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H, Vohra BP, Zhang Y, Heuckeroth RO.
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
    Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, Matsuo O, Niwa M, Akita K, Yamada Y, Yoshimi N, Uematsu T, Kojima S, Friedman SL, Moriwaki H, Mori H.
    Hepatology; 2001 Mar; 33(3):569-76. PubMed ID: 11230736
    [Abstract] [Full Text] [Related]

  • 15. Plasmin is not protective in experimental renal interstitial fibrosis.
    Edgtton KL, Gow RM, Kelly DJ, Carmeliet P, Kitching AR.
    Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease.
    López-Guisa JM, Rassa AC, Cai X, Collins SJ, Eddy AA.
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1244-54. PubMed ID: 21270094
    [Abstract] [Full Text] [Related]

  • 20. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S.
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.